Clairity, Inc. Information

Most medical images are read once, for the question of the day. Clairity builds AI-driven software that reads them again, for a different question: what is this person’s risk of disease in the years ahead? Clairity Breast™, estimates a woman’s five-year breast cancer risk from a screening mammogram she has already had. No new imaging. No questionnaire. The analysis runs after the radiologist has completed their interpretation, so it changes nothing about how her mammogram is read. Clairity Breast is FDA authorized, included in the NCCN Guidelines for Breast Cancer Screening and Diagnosis, and available through health systems and nationwide through Everlywell. About 85% of breast cancers occur in women with no family history, a factor traditional risk models weigh heavily. That gap is why image-based risk prediction matters, and it is not unique to breast cancer. Important safety information: clairity.com/information